- HOME
- Online Catalog
- Product Detail
Pentosidine
- Code:
- 3242-v
- Name:
- Pentosidine
- (S)-2-Amino-6-(2-(((S)-4-amino-4-carboxybutyl)amino)-4H-imidazo[4,5-b]pyridin-4-yl)hexanoic acid
- (Trifluoroacetate Form)
- (M.W. 378.43) C17H26N6O4
- Advanced Glycation End Product (AGE) / Biomarker for Glycation-Oxidative Stress e.g. in Diabetes
| Package | Price(Yen) | Availability |
|---|---|---|
| Vial 1 mg | 10,000 |
Ships within 1-3 business days |
| Bulk Request | ||
- main
- more information
- reference
main
- Purity:
- ≧98.0% (HPLC)
- Storage:
- -20 ℃
Solubility: H2O (5 mM)
more information
- Category:
- Enzyme Substrates and Related Peptides
reference
- D.R. Sell and V.M. Monnier, J. Biol. Chem., 264, 21597 (1989). (Original)
- T. Miyata, Y. Ueda, K. Horie, M. Nangaku, S. Tanaka, C.Y. Strihou, and K. Kurokawa, Kidney Int., 53, 416 (1998). (Pharmacol.)
- D. Slowik-Żylka, K. Safranow, V. Dziedziejko, H. Bukowska, K. Ciechanowski, and D. Chlubek, J. Biochem. Biophys. Methods, 61, 313 (2004). (Specific Determination of Pentosidine in Plasma)
- M. Saito and K. Marumo, Osteoporos. Int., 21, 195 (2010). (Clinical Review; Estimation of Fracture Risk)
- R. Furuya, H. Kumagai, T. Miyata, H. Fukasawa, S. Isobe, N. Kinoshita, and A. Hishida, Clin. Exp. Nephrol., 16, 421 (2012). (Clinical; Correlation to Cardiovascular Risk)
- M. Yamamoto and T. Sugimoto, Curr. Osteoporos. Rep., 14, 320 (2016). (Review)
SDS: Search other product
